About Scleroderma >
COVID-19 >
+ info

COVID-19

 

Dealing with COVID & Vaccines

A Canadian Scleroderma Series Panel Discussion

The discussion was held on February 11, 2021 and now the video is available to you. 

Featuring Panelists:
Dr. Janet Pope  –  Dr. Mark Larche  –  Dr. John Varga  –  Maureen Sauve

Moderator:
Dr. Brett D. Thombs

 

WATCH THE VIDEO HERE

 

One item in the video was reference to the American College of Rheumatology

Guidance Related to the Use and Timing of Vaccination and Immunomodulatory Therapies in Relation to COVID-19 Vaccination Administration in Rheumatoid Arthritis  Patients

You can have a look at COVID-19 Vaccine Clinical Guidance Summary

NOTE, PLEASE MAKE SURE YOU DISCUSS THIS WITH YOUR DOCTOR.

 


 

 

SPECIAL ANNOUNCEMENT

Thanks to the success of the SPIN-CHAT (COVID-19 Home-isolation Activities Together) Program and in response to public demand, we decided to offer weekly webinars of our educational segments! Starting February 2nd and held every Wednesday  4-5 PM PST thereafter, for a total of 11 webinars. Take a look at our presentation line-up below: 

Feb 02 Healthy information management Laura Dyas
Feb 10 Worry management Ghassan El-Baalbaki
Feb 17 Relaxation techniques Ghassan El-Baalbaki
Feb 24 Adapted home exercise Kelsey Ellis & Delaney Duchek
Mar 03 Home activity engagement Laura Bustamante
Mar 10 Worry management (Part 2) Ghassan El-Baalbaki
Mar 17 Relaxation techniques (Part 2) Ghassan El-Baalbaki
Mar 24 Adapted home exercise (Part 2) Kelsey Ellis & Delaney Duchek
Mar 31 Home activity engagement (Part 2) Laura Bustamante
Apr 07 Worry management (Part 3) Ghassan El-Baalbaki
Apr 14 Adapted home exercise (Part 3) Kelsey Ellis & Delaney Duchek

 

For the first session REGISTER HERE


 

COVID-19 presents important challenges for people affected by Scleroderma.  This page puts together available resources and pertinent information for Scleroderma patients, as well as the initiatives to support the organization and patients during these difficult times.

Scleroderma and the COVID vaccine.

Scleroderma Foundation in the United States pulled together a talented group of experts and have provided a page with information and recommendations on COVID-19 vaccines. Read what some of the top experts in the world have to say: READ HERE

Answers to your questions!

Immunosuppression is a risk factor, and having an interstitial lung disease (ILD) or Scleroderma without an ILD puts you at a slightly higher risk.

More information

COVID-19 and Scleroderma Q&A

BC Centre for Disease Control

BC Government Covid-19 Information

British Columbia division of the Canadian Mental Health Association

 

You have questions?  Please view this videoforum captured on March 21 2020.

« Scleroderma & COVID-19 : A conversation with the experts » 

Participants were invited to submit their questions concerning COVID-19 and Scleroderma in advance via an online Qualtrics questionnaire or to ask their questions directly to a team of five experienced panelists.  Mrs. Maureen Sauvé, Dr. Janet Pope, Dr. John Varga, Dr. Don Sheppard and Dr. Brett Thombs.  By typing them into the discussion section of GotoMeeting.

You can access a transcript of the questions and answers here!

 

Make the difference!

Every donation and effort help us to make a difference to advance research and to support people affected by scleroderma in British Columbia.  

Support research and scleroderma patients!